SMAD4 and neoplasm: To avoid cross-contamination of tumor cells with non-neoplastic cells, prior to sequencing, each tissue sample was first immunolabeled for the proteins encoded by most commonly altered tumor-suppressor genes inactivated in PDAC (CDKN2A, TP53, and SMAD4) (65).